THE ROLE OF THYROID STIMULATING IMMUNOGLOBULINS OF GRAVES'S DISEASE IN NEONATAL THYROTOXICOSIS
- 1 November 1978
- journal article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 85 (11), 837-843
- https://doi.org/10.1111/j.1471-0528.1978.tb15839.x
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Humoral and genetic factors in thyrotoxic Graves disease and neonatal thyrotoxicosisJAMA, 1976
- A Reconsideration of a Thyroid-Stimulating Immunoglobulin as the Cause of Hyperthyroidism in Graves' DiseaseJournal of Clinical Endocrinology & Metabolism, 1976
- Placental transmission of thyroid-stimulating immunoglobulins.BMJ, 1975
- Does lats cause hyperthyroidism in Graves' disease?: (A review biased toward the affirmative)Metabolism, 1972
- THE ROLE OF LONG ACTING THYROID STIMULATOR IN NEONATAL THYROTOXICOSISClinical Endocrinology, 1972
- Metabolism of 35S-labelled Antithyroid Drugs in ManBMJ, 1969
- Review: Pathogenesis of Graves' Disease: Role of the Long-acting Thyroid StimulatorJournal of Clinical Endocrinology & Metabolism, 1965
- THE INCIDENCE OF GOITRE DURING PREGNANCYThe Lancet, 1964
- Neonatal Graves' DiseaseJournal of Clinical Endocrinology & Metabolism, 1964
- THE USE OF ANTITHYROID DRUGS DURING PREGNANCY*†Journal of Clinical Endocrinology & Metabolism, 1951